Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nonpulmonary manifestations of sarcoidosis.

Literature DB >> 11890883

Nonpulmonary manifestations of sarcoidosis.

Abstract

Sarcoidosis is one in a heterogeneous family of granulomatous disorders. The clinical manifestations of sarcoidosis can vary widely, depending on the patient and the tissues involved. Recent advances in our understanding of the immunologic steps leading to granuloma formation and persistence have yet to translate into more effective care for patients with this disease. This review discusses the immunology of granuloma formation and systemic disease, the various nonpulmonary expressions of the clinical disease, and the treatment options available to the practicing physician.

Entities: Disease Species

Mesh：

Year: 2002 PMID： 11890883 DOI： 10.1007/s11926-002-0013-1

Source DB: PubMed Journal: Curr Rheumatol Rep ISSN： 1523-3774 Impact factor: 4.592

52 in total

Review 1. Ocular involvement in sarcoidosis.

Authors: A Rothova
Journal: Br J Ophthalmol Date: 2000-01 Impact factor: 4.638

2. Immune stimulation in scleroderma patients treated with thalidomide.

Authors: S J Oliver; A Moreira; G Kaplan
Journal: Clin Immunol Date: 2000-11 Impact factor: 3.969

3. The treatment of sarcoidosis with chloroquine.

Authors: S I MORSE; Z A COHN; J G HIRSCH; R W SCHAEDER
Journal: Am J Med Date: 1961-05 Impact factor: 4.965

Review 4. New pathogenetic insights into the sarcoid granuloma.

Authors: C Agostini; F Adami; G Semenzato
Journal: Curr Opin Rheumatol Date: 2000-01 Impact factor: 5.006

5. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study.

Authors: H Eule; A Weinecke; I Roth; H Wuthe
Journal: Ann N Y Acad Sci Date: 1986 Impact factor: 5.691

6. Sarcoidosis of bone.

Authors: E Neville; L S Carstairs; D G James
Journal: Q J Med Date: 1977-04

7. Treatment of cutaneous sarcoidosis with isotretinoin.

Authors: T P Waldinger; C N Ellis; K Quint; J J Voorhees
Journal: Arch Dermatol Date: 1983-12

8. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis.

Authors: J D Forman; J T Klein; R F Silver; M C Liu; B M Greenlee; D R Moller
Journal: J Clin Invest Date: 1994-10 Impact factor: 14.808

9. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.

Authors: M Carlesimo; S Giustini; A Rossi; P Bonaccorsi; S Calvieri
Journal: J Am Acad Dermatol Date: 1995-05 Impact factor: 11.527

10. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset.

Authors: P A Haslett; L G Corral; M Albert; G Kaplan
Journal: J Exp Med Date: 1998-06-01 Impact factor: 14.307

2 in total

1. [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].

Authors: A Waltschew
Journal: Pathologe Date: 2016-03 Impact factor: 1.011

2. Sarcoidosis presenting as an osteolytic skull lesion: a case report and review of literature on skull sarcoidosis.

Authors: Mario Fernández-Ruiz; Juan-Manuel Guerra-Vales; Francisco-Javier Castelbón-Fernández; Jara Llenas-García; Jose-Luis Rodríguez-Peralto; Roberto López-Lancho; Irene Redondo-Marcos
Journal: Clin Rheumatol Date: 2007-01-03 Impact factor: 3.650

2 in total